Pablo Mandó
Impact in
-
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- CAR-T cell therapy research
-
- Breast Cancer Treatment Studies
Papers in
- Oncology 16
- Cancer Immunotherapy and Biomarkers 7
- HER2/EGFR in Cancer Research 3
- Inflammatory Biomarkers in Disease Prognosis 2
- CAR-T cell therapy research 2
-
- Advanced Breast Cancer Therapies 6
- Co-authors
- Manglio Rizzo (9 shared papers)Estrella Mariel Levy (6 shared papers)Federico Waisberg (10 shared papers)Jorge Carlos Nadal (6 shared papers)José Mordoh (4 shared papers)Claudio Marcelo Martin (4 shared papers)Adrián Nervo (6 shared papers)Gerardo Rubén Cueto (2 shared papers)
In The Last Decade
Pablo Mandó
30 papers receiving 256 citations
Peers
Comparison fields: 5 of 41
- Oncology 148
- Cancer Research 41
- Immunology 37
- Pulmonary and Respiratory Medicine 40
- Radiology, Nuclear Medicine and Imaging 24
Countries citing papers authored by Pablo Mandó
This map shows the geographic impact of Pablo Mandó's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Mandó with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Mandó more than expected).
Fields of papers citing papers by Pablo Mandó
This network shows the impact of papers produced by Pablo Mandó. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Mandó. The network helps show where Pablo Mandó may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Mandó, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 45 | |
| 2 | 2019 | 41 | |
| 3 | 2020 | 36 | |
| 4 | 2020 | 21 | |
| 5 | 2025 | 15 | |
| 6 | 2018 | 12 | |
| 7 | 2023 | 9 | |
| 8 | 2021 | 9 | |
| 9 | 2021 | 9 | |
| 10 | 2017 | 8 | |
| 11 | 2018 | 8 | |
| 12 | 2022 | 7 | |
| 13 | 2023 | 5 | |
| 14 | 2022 | 4 | |
| 15 | 2017 | 4 | |
| 16 | 2020 | 4 | |
| 17 | 2023 | 3 | |
| 18 | 2022 | 3 | |
| 19 | 2025 | 2 | |
| 20 | 2023 | 2 |
About Pablo Mandó
Pablo Mandó is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Public Health, Environmental and Occupational Health and Radiology, Nuclear Medicine and Imaging, having authored 37 papers that have together received 259 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (7 papers), Advanced Breast Cancer Therapies (6 papers), Breast Cancer Treatment Studies (3 papers), HER2/EGFR in Cancer Research (3 papers), Immune Cell Function and Interaction (3 papers), Inflammatory Biomarkers in Disease Prognosis (2 papers), CAR-T cell therapy research (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Oncology (148 citations), Cancer Research (41 citations), Immunology (37 citations), Pulmonary and Respiratory Medicine (40 citations) and Radiology, Nuclear Medicine and Imaging (24 citations). Pablo Mandó has collaborated with scholars based in Argentina, Brazil and Italy. Frequent co-authors include Manglio Rizzo, Estrella Mariel Levy, Federico Waisberg, Jorge Carlos Nadal, José Mordoh, Claudio Marcelo Martin, Adrián Nervo, Gerardo Rubén Cueto, Matias Rodrigo Chacon and Alicia Bravo. Their work appears in journals such as JCO Global Oncology, ESMO Open, Annals of Oncology, Critical Reviews in Oncology/Hematology and Breast Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.